ReviewCell proliferation2022

Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy.

Yuika Morita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.